AIDS Malignancies Training and Research International Program (AMTRIP)
艾滋病恶性肿瘤培训和研究国际计划 (AMTRIP)
基本信息
- 批准号:10542913
- 负责人:
- 金额:$ 28.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-01 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
PROJECT SUMMARY/ABSTRACT
HIV/AIDS is at epidemic proportions in Zambia, where approximately 1.2 million people – representing about
12% of the country's adult population – are infected. Concomitant with this epidemic, the widespread
availability of free anti-retroviral treatment in-country has increased the lifespan of HIV-1 infected individuals,
resulting in prolonged chronic immunosuppression and increased occurrence of HIV-associated cancers.
However, in-country efforts to prevent, diagnose, and manage cancer in Zambia have been hindered by a lack
of laboratory facilities, insufficient cancer research infrastructure, and a shortage of trained personnel.
Recognizing these critical gaps, the University of Zambia School of Medicine, the University Teaching
Hospitals, and the University of Nebraska-Lincoln leveraged the success of a previous Fogarty partnership to
establish the AIDS Malignancies Training and Research International Program (AMTRIP) in collaboration with
a new lead partner, the Cancer Diseases Hospital (CDH). This unique program aims to enhance Zambia's
cancer research infrastructure and capacity by training Zambian biomedical researchers and health care
providers in laboratory techniques and research methodology related to basic cancer biology, molecular
genomics, and bioinformatics. Now in its fifth year, AMTRIP has made significant strides by providing intensive
long-term graduate degree training and short- and medium-term technical training for a diverse group of 25
trainees; hosting workshops for over 300 health care professionals; successfully transitioning trainees into
mentorship roles; adapting program activities to meet the needs of trainees and the rapidly changing cancer
research landscape; and leveraging partnerships with other D43 programs to expand the program's impact.
Building on these accomplishments, this renewal application seeks to further enhance cancer research
capacity in Zambia by: 1) continuing to provide long-term academic instruction and research experiences for
eight current master's and three current PhD students in Zambia and recruiting four additional master's and
two additional PhD students; 2) providing medium-term (six months to one year) technical training for trainees
in topics related to molecular pathology, cancer biology, bioinformatics and genomics; and 3) delivering short-
term training (less than three months) and technical workshops (3-5 days) designed to enhance basic, clinical,
implementation, genomics, bioinformatics, and behavioral cancer research in collaboration with other regional
partners and programs. Expected outcomes of this renewal include the graduation of eight current master's
and three current PhD candidates; recruitment and training of an additional four master's and two PhD
students in relevant cancer research fields; the transition of trainees into mentorship roles; enhanced
infrastructure at Zambian institutions, including the completion of a CDH laboratory renovation; and expanded
partnerships with other D43 programs. Given current progress and anticipated renewal outcomes, AMTRIP is
on track to transition program leadership to the next generation of cancer researchers in a future renewal.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Chipepo Kankasa其他文献
Chipepo Kankasa的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Chipepo Kankasa', 18)}}的其他基金
AIDS Malignancies Training and Research International Program (AMTRIP)
艾滋病恶性肿瘤培训和研究国际计划 (AMTRIP)
- 批准号:
10618999 - 财政年份:2022
- 资助金额:
$ 28.71万 - 项目类别:
AIDS Malignancies Training and Research International Program (AMTRIP)
艾滋病恶性肿瘤培训和研究国际计划 (AMTRIP)
- 批准号:
10405562 - 财政年份:2022
- 资助金额:
$ 28.71万 - 项目类别:
The Zambia AIDS Malignancies Diagnosis and Pathogenesis Program (ZAMDAPP)
赞比亚艾滋病恶性肿瘤诊断和发病机制计划 (ZAMDAPP)
- 批准号:
9404820 - 财政年份:2017
- 资助金额:
$ 28.71万 - 项目类别:
Zambia AIDS Malignancies Diagnosis and Pathogenesis Program Supplement
赞比亚艾滋病恶性肿瘤诊断和发病机制计划补充资料
- 批准号:
10381368 - 财政年份:2017
- 资助金额:
$ 28.71万 - 项目类别:
The Zambia AIDS Malignancies Diagnosis and Pathogenesis Program (ZAMDAPP)
赞比亚艾滋病恶性肿瘤诊断和发病机制计划 (ZAMDAPP)
- 批准号:
10242673 - 财政年份:2017
- 资助金额:
$ 28.71万 - 项目类别:
相似海外基金
Tanzania AIDS Malignancies Training and Research International Program (TAMTRP)
坦桑尼亚艾滋病恶性肿瘤培训和研究国际计划 (TAMTRP)
- 批准号:
10650673 - 财政年份:2022
- 资助金额:
$ 28.71万 - 项目类别:
Tanzania AIDS Malignancies Training and Research Program (TAMTRP)
坦桑尼亚艾滋病恶性肿瘤培训和研究计划 (TAMTRP)
- 批准号:
10472142 - 财政年份:2022
- 资助金额:
$ 28.71万 - 项目类别:
AIDS Malignancies Training and Research International Program (AMTRIP)
艾滋病恶性肿瘤培训和研究国际计划 (AMTRIP)
- 批准号:
10618999 - 财政年份:2022
- 资助金额:
$ 28.71万 - 项目类别:
Tanzania AIDS Malignancies Training and Research Program (TAMTRP)
坦桑尼亚艾滋病恶性肿瘤培训和研究计划 (TAMTRP)
- 批准号:
10601111 - 财政年份:2022
- 资助金额:
$ 28.71万 - 项目类别:
AIDS Malignancies Training and Research International Program (AMTRIP)
艾滋病恶性肿瘤培训和研究国际计划 (AMTRIP)
- 批准号:
10405562 - 财政年份:2022
- 资助金额:
$ 28.71万 - 项目类别:
UM CFAR SCCC Argentina Consortium for research and training in Virally Induced AIDS Malignancies
UM CFAR SCCC 阿根廷病毒引起的艾滋病恶性肿瘤研究和培训联盟
- 批准号:
9767729 - 财政年份:2017
- 资助金额:
$ 28.71万 - 项目类别:
UM CFAR SCCC Argentina Consortium for research and training in Virally Induced AIDS Malignancies
UM CFAR SCCC 阿根廷病毒引起的艾滋病恶性肿瘤研究和培训联盟
- 批准号:
10488063 - 财政年份:2017
- 资助金额:
$ 28.71万 - 项目类别:
UM CFAR SCCC Argentina Consortium for research and training in Virally Induced AIDS Malignancies
UM CFAR SCCC 阿根廷病毒引起的艾滋病恶性肿瘤研究和培训联盟
- 批准号:
10246315 - 财政年份:2017
- 资助金额:
$ 28.71万 - 项目类别:
AIDS Malignancies Training and Research International Program (AMTRIP)
艾滋病恶性肿瘤培训和研究国际计划 (AMTRIP)
- 批准号:
9886301 - 财政年份:2016
- 资助金额:
$ 28.71万 - 项目类别:
AIDS Malignancies Training and Research International Program (AMTRIP)
艾滋病恶性肿瘤培训和研究国际计划 (AMTRIP)
- 批准号:
9258516 - 财政年份:2016
- 资助金额:
$ 28.71万 - 项目类别: